Search research articles
Contact Us
Filters
Showing results (171-180 of 251) with videos related to
Page
of 26
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 26, 2017
Dynamic molecular analysis and clinical correlates of tumor evolution within a phase II trial of panitumumab-based therapy in metastatic colorectal cancer
S Siena, A Sartore-Bianchi, R Garcia-Carbonero, et al.
Acta Gastro-Enterologica Belgica
|
May 1, 2009
Role of chemotherapy in gastro-entero-pancreatic neuroendocrine tumors: the end of a story?
T Delaunoit, M Van den Eynde, I Borbath, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 14, 2000
Utility of positron emission tomography for the staging of patients with potentially operable esophageal carcinoma
P Flamen, A Lerut, E Van Cutsem, et al.
ESMO Open
|
August 9, 2021
Quality of life with first-line pembrolizumab for PD-L1-positive advanced gastric/gastroesophageal junction adenocarcinoma: results from the randomised phase III KEYNOTE-062 study
E Van Cutsem, A Valderrama, Y-J Bang, et al.
ESMO Open
|
June 27, 2021
Trifluridine/tipiracil versus placebo for third or later lines of treatment in metastatic gastric cancer: an exploratory subgroup analysis from the TAGS study
J Tabernero, K Shitara, A Zaanan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 21, 2015
Survival following early-stage colon cancer: an ACCENT-based comparison of patients versus a matched international general population†
L A Renfro, A Grothey, D Kerr, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 21, 2012
Radiofrequency ablation combined with systemic treatment versus systemic treatment alone in patients with non-resectable colorectal liver metastases: a randomized EORTC Intergroup phase II study (EORTC 40004)
T Ruers, C Punt, F Van Coevorden, et al.
Acta Gastro-Enterologica Belgica
|
May 1, 2009
Carcinoid heart disease--a hidden complication of neuroendocrine tumours
I Dero, M De Pauw, I Borbath, et al.
European Radiology
|
July 12, 2015
Comparison of diagnostic accuracy of (111)In-pentetreotide SPECT and (68)Ga-DOTATOC PET/CT: A lesion-by-lesion analysis in patients with metastatic neuroendocrine tumours
S Van Binnebeek, B Vanbilloen, K Baete, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 12, 2002
Adjuvant treatment of colorectal cancer (current expert opinion derived from the Third International Conference: Perspectives in Colorectal Cancer, Dublin, 2001)
E Van Cutsem, M Dicato, J Wils, et al.
Page
of 26
Search research articles
Search
Showing results (171-180 of 251) with videos related to
Sort By:
Page
of 26
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 26, 2017
Dynamic molecular analysis and clinical correlates of tumor evolution within a phase II trial of panitumumab-based therapy in metastatic colorectal cancer
S Siena, A Sartore-Bianchi, R Garcia-Carbonero, et al.
Acta Gastro-Enterologica Belgica
|
May 1, 2009
Role of chemotherapy in gastro-entero-pancreatic neuroendocrine tumors: the end of a story?
T Delaunoit, M Van den Eynde, I Borbath, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 14, 2000
Utility of positron emission tomography for the staging of patients with potentially operable esophageal carcinoma
P Flamen, A Lerut, E Van Cutsem, et al.
ESMO Open
|
August 9, 2021
Quality of life with first-line pembrolizumab for PD-L1-positive advanced gastric/gastroesophageal junction adenocarcinoma: results from the randomised phase III KEYNOTE-062 study
E Van Cutsem, A Valderrama, Y-J Bang, et al.
ESMO Open
|
June 27, 2021
Trifluridine/tipiracil versus placebo for third or later lines of treatment in metastatic gastric cancer: an exploratory subgroup analysis from the TAGS study
J Tabernero, K Shitara, A Zaanan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 21, 2015
Survival following early-stage colon cancer: an ACCENT-based comparison of patients versus a matched international general population†
L A Renfro, A Grothey, D Kerr, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 21, 2012
Radiofrequency ablation combined with systemic treatment versus systemic treatment alone in patients with non-resectable colorectal liver metastases: a randomized EORTC Intergroup phase II study (EORTC 40004)
T Ruers, C Punt, F Van Coevorden, et al.
Acta Gastro-Enterologica Belgica
|
May 1, 2009
Carcinoid heart disease--a hidden complication of neuroendocrine tumours
I Dero, M De Pauw, I Borbath, et al.
European Radiology
|
July 12, 2015
Comparison of diagnostic accuracy of (111)In-pentetreotide SPECT and (68)Ga-DOTATOC PET/CT: A lesion-by-lesion analysis in patients with metastatic neuroendocrine tumours
S Van Binnebeek, B Vanbilloen, K Baete, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 12, 2002
Adjuvant treatment of colorectal cancer (current expert opinion derived from the Third International Conference: Perspectives in Colorectal Cancer, Dublin, 2001)
E Van Cutsem, M Dicato, J Wils, et al.
Page
of 26